510(k) Report

510(k) · Cleared

Cleared

Enzygnost F+2 (Monoclonal) Test Kit

K042687510(k) TraditionalCleared Dec 10, 200472-day reviewClass II21 CFR 864.7320

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Dade Behring, Inc. · MIF Prothrombin Fragment 1.2

Cleared on Dec 10, 2004 as substantially equivalent to K922934 (Behring Diagnostics, Inc., 1992) after a 72-day review. Its family tree reaches back 1 generation to 1992.

Decided
Dec 10, 2004
Review
72 days
Class
Class II
Product code
MIF
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K922934 (1992). No later device cites it as a predicate yet.

K922934 · Enzygnost F 1+2 · Behring Diagnostics, Inc. · 19921990199520002005
K922934 · Enzygnost F 1+2 · Behring Diagnostics, Inc. · 19920
  1. Root · 1 generation backK922934 Enzygnost F 1+2Behring Diagnostics, Inc. · 1992
  2. This deviceK042687 Enzygnost F+2 (Monoclonal) Test KitDade Behring, Inc. · 2004
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K922934Enzygnost F 1+2Behring Diagnostics, Inc.1992—
0 (this device)K042687Enzygnost F+2 (Monoclonal) Test KitDade Behring, Inc.2004—
FIG. 1 — Lineage of K042687, 1992–2004Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MIF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K922934Enzygnost F 1+2
Summary page 1
…3. FDA Classification Name: Fibrinogen/Fibrin degradation products assay 4. Predicate Device: EnzygnostTM F1+2 micro test kit (K922934) 5. Device Description: The EnzygnostTM F1+2 Test Kit is an enzyme immunoassay based on the sandwich principle in microti…
Behring Diagnostics, Inc.1992—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All MIF devices

MIF Prothrombin Fragment 1.2: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MIF

FDA has decided no MIF device since 2007.

Median 510(k) review, days · MIF

Too few MIF 510(k)s in any year since 2007 to give a median.

Recalls per year · MIF

No recall names MIF since 2007.

Adverse event reports per year · MIF

No MAUDE report names MIF since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

Enzygnost F1 +2 (monoclonal) is an enzyme immunoassay for the quantitative

determination of human prothrombin F1 +2 in plasma. Measurement of F1+2 is used as

an aid in the diagnosis, monitoring, and evaluation of acquired or hereditary blood

coagulation disorders. It is indicated as an aid in assessing risk of thrombosis and in

monitoring efficacy of anticoagulant therapy.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K042687: Enzygnost F+2 (Monoclonal) Test Kit.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K042687

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026